Literature DB >> 20158946

Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits.

Aruna Panda1, Ivan Tatarov, Angela R Melton-Celsa, Krishnan Kolappaswamy, Edwin H Kriel, Daniel Petkov, Turhan Coksaygan, Sofie Livio, Charles G McLeod, James P Nataro, Alison D O'Brien, Louis J DeTolla.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) produce one or more types of Shiga toxins and are foodborne causes of bloody diarrhea. The prototype EHEC strain, Escherichia coli O157:H7, is responsible for both sporadic cases and serious outbreaks worldwide. Infection with E. coli that produce Shiga toxins may lead to diarrhea, hemorrhagic colitis, or (less frequently) hemolytic uremic syndrome, which can cause acute kidney failure. The exact mechanism by which EHEC evokes intestinal and renal disease has not yet been determined. The development of a readily reproducible animal oral-infection model with which to evaluate the full pathogenic potential of E. coli O157:H7 and assess the efficacy of therapeutics and vaccines remains a research priority. Dutch belted (DB) rabbits are reported to be susceptible to both natural and experimental EHEC-induced disease, and New Zealand white (NZW) rabbits are a model for the intestinal manifestations of EHEC infection. In the current study, we compared the pathology caused by E. coli O157:H7 infection in DB and NZW rabbits. Both breeds of rabbits developed clinical signs of disease and intestinal lesions after experimental infection. In addition, one of the infected DB rabbits developed renal lesions. Our findings provide evidence that both breeds are susceptible to E. coli O157:H7 infection and that both may be useful models for investigating EHEC infections of humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20158946      PMCID: PMC2826082     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  40 in total

Review 1.  Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells.

Authors:  E V O'Loughlin; R M Robins-Browne
Journal:  Microbes Infect       Date:  2001-05       Impact factor: 2.700

2.  Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor.

Authors:  N Mani; B Dupuy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

4.  Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.

Authors:  A Donohue-Rolfe; I Kondova; S Oswald; D Hutto; S Tzipori
Journal:  J Infect Dis       Date:  2000-05-09       Impact factor: 5.226

Review 5.  Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.

Authors:  F Proulx; E G Seidman; D Karpman
Journal:  Pediatr Res       Date:  2001-08       Impact factor: 3.756

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli.

Authors:  Jon B Woods; Clare K Schmitt; Stephen C Darnell; Karen C Meysick; Alison D O'Brien
Journal:  J Infect Dis       Date:  2002-01-22       Impact factor: 5.226

8.  A naturally occurring rabbit model of enterohemorrhagic Escherichia coli-induced disease.

Authors:  Alexis García; Robert P Marini; Yan Feng; Allison Vitsky; Kimberly A Knox; Nancy S Taylor; David B Schauer; James G Fox
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

Review 9.  Epidemiology and spectrum of disease of Escherichia coli O157.

Authors:  Theresa J Ochoa; Thomas G Cleary
Journal:  Curr Opin Infect Dis       Date:  2003-06       Impact factor: 4.915

10.  Direct PCR detection of Escherichia coli O157:H7.

Authors:  K A Fode-Vaughan; J S Maki; J A Benson; M L P Collins
Journal:  Lett Appl Microbiol       Date:  2003       Impact factor: 2.858

View more
  10 in total

1.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

2.  Infant Rabbit Model for Studying Shiga Toxin-Producing Escherichia coli.

Authors:  Jennifer M Ritchie
Journal:  Methods Mol Biol       Date:  2021

3.  Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.

Authors:  K A Eaton; C Fontaine; D I Friedman; N Conti; C J Alteri
Journal:  Vet Pathol       Date:  2017-02-08       Impact factor: 2.221

4.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

Review 5.  Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.

Authors:  Victor A Garcia-Angulo; Anjana Kalita; Alfredo G Torres
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

6.  Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.

Authors:  Deborah J Stearns-Kurosawa; Sun-Young Oh; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh; James Papin; Joel Henderson; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2013-02-10       Impact factor: 4.307

7.  Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin.

Authors:  T Zangari; A R Melton-Celsa; A Panda; M A Smith; I Tatarov; L De Tolla; A D O'Brien
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

8.  Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.

Authors:  Tom G Obrig
Journal:  Toxins (Basel)       Date:  2010-12-02       Impact factor: 4.546

Review 9.  Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli.

Authors:  Su-Bin Hwang; Ramachandran Chelliah; Ji Eun Kang; Momna Rubab; Eric Banan-MwineDaliri; Fazle Elahi; Deog-Hwan Oh
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

10.  In vivo screening platform for shiga toxin-producing Escherichia coli (STEC) using Caenorhabditis elegans as a model.

Authors:  Su-Bin Hwang; Jung-Gu Choi; Shuai Wei; Byung-Jae Park; Ramachandran Chelliah; Deog-Hwan Oh
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.